PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Topiramate 250mg/5ml oral suspension
040801050AABZBZ
Topiramate Topiramate Central Nervous System No data available
Topiramate 25mg/5ml oral solution
040801050AACECE
Topiramate Topiramate Central Nervous System No data available
Topiramate 30mg/5ml oral liquid
040801050AABLBL
Topiramate Topiramate Central Nervous System No data available
Topiramate 35mg/5ml oral liquid
040801050AABRBR
Topiramate Topiramate Central Nervous System No data available
Topiramate 5mg/5ml oral liquid
040801050AABIBI
Topiramate Topiramate Central Nervous System No data available
Topiramate 6.25mg/5ml oral liquid
040801050AABHBH
Topiramate Topiramate Central Nervous System No data available
Topiramate 62.5mg/5ml oral suspension
040801050AACDCD
Topiramate Topiramate Central Nervous System No data available
Topiramate 67.5mg/5ml oral liquid
040801050AABUBU
Topiramate Topiramate Central Nervous System No data available
Topiramate 75mg/5ml oral liquid
040801050AAASAS
Topiramate Topiramate Central Nervous System No data available
Topiramate 8mg/5ml oral suspension
040801050AACFCF
Topiramate Topiramate Central Nervous System No data available
Topogyne 400microgram tablets
0701010X0BBAAAA
Topogyne Misoprostol (Gynaecology) Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Topotecan 1mg capsules
0801050AFAAADAD
Topotecan Topotecan Malignant Disease and Immunosuppression No data available
Topotecan 1mg powder for solution for infusion vials
0801050AFAAAAAA
Topotecan Topotecan Malignant Disease and Immunosuppression No data available
Topotecan 1mg/1ml solution for infusion vials
0801050AFAAAFAF
Topotecan Topotecan Malignant Disease and Immunosuppression No data available
Topotecan 250microgram capsules
0801050AFAAACAC
Topotecan Topotecan Malignant Disease and Immunosuppression No data available
Topotecan 4mg powder for solution for infusion vials
0801050AFAAABAB
Topotecan Topotecan Malignant Disease and Immunosuppression No data available
Topotecan 4mg/4ml solution for infusion vials
0801050AFAAAEAE
Topotecan Topotecan Malignant Disease and Immunosuppression No data available
Toradol 10mg tablets
1501042E0BBACAC
Toradol Ketorolac trometamol Anaesthesia No data available
Toradol 10mg/1ml solution for injection ampoules
1501042E0BBABAB
Toradol Ketorolac trometamol Anaesthesia No data available
Torasemide 20mg tablets
0202020U0AAAFAF
Torasemide Torasemide Cardiovascular System No data available
Torbetol acne lotion
1311020L0CEAAA0
Torbetol (Topical) Chlorhexidine gluconate Skin No data available
Torisel 30mg/1.2ml concentrate for inf vials and diluent
0801050AUBBAAAA
Torisel Temsirolimus Malignant Disease and Immunosuppression No data available
Trabectedin 1mg powder for solution for infusion vials
0801050AVAAABAB
Trabectedin Trabectedin Malignant Disease and Immunosuppression No data available
Trabectedin 250microgram inf vials
0801050AVAAAAAA
Trabectedin Trabectedin Malignant Disease and Immunosuppression No data available
TracFlex Plus shower cap
20050200326
TracFlex Plus shower cap Tracheostomy & Laryngectomy Appliances Dressings No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.